Shandong Xinhua Pharmaceutical Co. Ltd. provided earnings guidance for the third quarter and nine months ended September 30, 2012. For the quarter, the company expects net profit attributable to the shareholders of the company from RMB 800,000 to ­RMB 8,800,000 and basic EPS from RMB 0.0017 to RMB 0.019.

For the nine months, the company expects net profit attributable to the shareholders of the company from RMB 32,000,000 to ­RMB 40,000,000 and basic EPS from RMB 0.069 to RMB 0.087.